Sponsor Pipeline

Qinghai Red Cross Hospital Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
5
Recruiting
3
Phase 3
1
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-15 NCT07489625
Hydromorphone With Electroacupuncture and Ear Acupoint Pressing for Refractory Cancer Pain
Recruitment opened
Active Trials by Phase
Phase 3
3
Phase 2
1
Early Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06338683 Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper… Advanced Cancer Recruiting
NCT06859190 Efficacy of Auricular Pressure Beans with Electroacupuncture and Estazolam Treating… Cancer Recruiting
NCT07423390 Study on the Efficacy and Safety of Mecobalamin in Preventing Taxane-related Peripheral… Peripheral Neuropathy Due to Chemotherapy Recruiting
Phase 2
NCT06891521 Electroacupuncture for Preventing Adverse Events of Cancer Immunotherapy Cancer Not Yet Recruiting
Early Phase 1
NCT07489625 Hydromorphone With Electroacupuncture and Ear Acupoint Pressing for Refractory Cancer Pain Refractory Cancer Pain Recruiting
Not specified
NCT06915389 Metabolomic and Lipidomic Analysis Predicts Immunotherapy-related Adverse Events in… Gastric Cancer Recruiting
Disease Areas
Get alerts when Qinghai Red Cross Hospital's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free